Drugs / EPI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01852799 | Dec 2012 → Sep 2016 | plasma cell myeloma | Shanghai Changzheng Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPI | “or EPI (15mg/m2, iv, on days 1-4 of each 28 day cycle)” NCT01852799 ↗ |
| Route | Intravenous | “EPI (15mg/m2, iv, on days 1-4 of each 28 day cycle)” NCT01852799 ↗ |